Clinical trial NCT06257667 - References

COPD — Treatment of Acute Hypercapnic Respiratory Failure With OptiflowTM or Optiflow+DuetTM Nasal Cannula in COPD-patients

Citation(s)

•   Agusti A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca M, Mortimer K, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Singh D, Stockley R, Lopez Varela MV, Wedzicha JA, Vogelmeier CF
  Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023 Apr 1;61(4):2300239. doi: 10.1183/13993003.00239-2023. Print 2023 Apr.
•   Ahmad N, Taithongchai A, Sadiq R, Mustfa N
  Acute hypercapnic respiratory failure (AHRF): looking at long-term mortality, prescription of long-term oxygen therapy and chronic non-invasive ventilation (NIV). Clin Med (Lond). 2012 Apr;12(2):188. doi: 10.7861/clinmedicine.12-2-188. No abstract available.
•   Akbas T, Gunes H
  Characteristics and outcomes of patients with chronic obstructive pulmonary disease admitted to the intensive care unit due to acute hypercapnic respiratory failure. Acute Crit Care. 2023 Feb;38(1):49-56. doi: 10.4266/acc.2022.01011. Epub 2023 Feb 27.
•   Cammarota G, Simonte R, De Robertis E
  Comfort During Non-invasive Ventilation. Front Med (Lausanne). 2022 Mar 24;9:874250. doi: 10.3389/fmed.2022.874250. eCollection 2022. Erratum In: Front Med (Lausanne). 2023 Apr 04;10:1193466.
•   Cortegiani A, Longhini F, Carlucci A, Scala R, Groff P, Bruni A, Garofalo E, Taliani MR, Maccari U, Vetrugno L, Lupia E, Misseri G, Comellini V, Giarratano A, Nava S, Navalesi P, Gregoretti C
  High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Trials. 2019 Jul 22;20(1):450. doi: 10.1186/s13063-019-3514-1.
•   Cortegiani A, Longhini F, Madotto F, Groff P, Scala R, Crimi C, Carlucci A, Bruni A, Garofalo E, Raineri SM, Tonelli R, Comellini V, Lupia E, Vetrugno L, Clini E, Giarratano A, Nava S, Navalesi P, Gregoretti C; H
  F.-AECOPD study investigators. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care. 2020 Dec 14;24(1):692. doi: 10.1186/s13054-020-03409-0.
•   Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta JJ, Cabrera C, Zagaceta J, Sanchez-Salcedo P, Berto J, Davila RB, Alcaide AB, Cote C, Celli BR; BODE Collaborative Group
  COPD comorbidities network. Eur Respir J. 2015 Sep;46(3):640-50. doi: 10.1183/09031936.00171614. Epub 2015 Jul 9.
•   Eikhof KD, Olsen KR, Wrengler NC, Nielsen C, Bodtger U, Titlestad IL, Weinreich UM
  Undiagnosed chronic obstructive pulmonary disease in patients admitted to an acute assessment unit. Eur Clin Respir J. 2017 Mar 8;4(1):1292376. doi: 10.1080/20018525.2017.1292376. eCollection 2017.
•   Huang Y, Lei W, Zhang W, Huang JA
  High-Flow Nasal Cannula in Hypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis. Can Respir J. 2020 Oct 29;2020:7406457. doi: 10.1155/2020/7406457. eCollection 2020.
•   Jeong JH, Kim DH, Kim SC, Kang C, Lee SH, Kang TS, Lee SB, Jung SM, Kim DS
  Changes in arterial blood gases after use of high-flow nasal cannula therapy in the ED. Am J Emerg Med. 2015 Oct;33(10):1344-9. doi: 10.1016/j.ajem.2015.07.060. Epub 2015 Jul 30.
•   Kim ES, Lee H, Kim SJ, Park J, Lee YJ, Park JS, Yoon HI, Lee JH, Lee CT, Cho YJ
  Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis. 2018 Feb;10(2):882-888. doi: 10.21037/jtd.2018.01.125.
•   Ozyilmaz E, Ugurlu AO, Nava S
  Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med. 2014 Feb 13;14:19. doi: 10.1186/1471-2466-14-19.
•   Pinkham M, Tatkov S
  Effect of flow and cannula size on generated pressure during nasal high flow. Crit Care. 2020 May 24;24(1):248. doi: 10.1186/s13054-020-02980-w. No abstract available.
•   Scala R
  Challenges on non-invasive ventilation to treat acute respiratory failure in the elderly. BMC Pulm Med. 2016 Nov 15;16(1):150. doi: 10.1186/s12890-016-0310-5.
•   Suzuki A, Ando M, Kimura T, Kataoka K, Yokoyama T, Shiroshita E, Kondoh Y
  The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial. BMC Pulm Med. 2020 Feb 24;20(1):51. doi: 10.1186/s12890-020-1093-2.
•   Waeijen-Smit K, Jacobsen PA, Houben-Wilke S, Simons SO, Franssen FME, Spruit MA, Pedersen CT, Kragholm KH, Weinreich UM
  All-cause admissions following a first ever exacerbation-related hospitalisation in COPD. ERJ Open Res. 2023 Jan 3;9(1):00217-2022. doi: 10.1183/23120541.00217-2022. eCollection 2023 Jan.

Randomized Controlled Trial to Investigate the Effect of High Flow Nasal Cannula Treatment on Carbon Dioxide-levels in COPD- Patients With Acute Hypercapnic Respiratory Failure, Using Either OptiflowTM or Optiflow+DuetTM Nasal Cannula

Details for clinical trial NCT06257667